Table 3 Distribution of group A rotavirus G/P genotypes during the fourth to seventh year after the introduction of vaccines, n (%)
|  | Nov 2010–Oct-11 | Nov 2011–Oct-12 | Nov 2012–Oct-13 | Nov 2013–Oct-14 | Total |
|---|---|---|---|---|---|
Common genotypes | |||||
G2P[4] | 8 (18.6) | 1 (4.8) | 17 (22.4) | 7 (17.9) | 33 (18.4) |
G1P[8] | 5 (11.6) | 8 (38.1) | 12 (15.8) | 1 (2.6) | 26 (14.5) |
G3P[8] | 3 (7.0) | 1 (4.8) | 3 (3.9) | 2 (5.1) | 9 (5.0) |
G9P[8] | 1 (2.3) | 2 (9.5) | 1 (1.3) | 1 (2.6) | 5 (2.8) |
G4P[6] | 0 | 0 | 0 | 1 (2.6) | 1 (0.6) |
G4P[8] | 1 (2.3) | 0 | 0 | 0 | 1 (0.6) |
subtotal | 18 (41.9) | 12 (57.1) | 33 (43.4) | 12 (30.8) | 75 (41.9) |
Uncommon genotypes | |||||
G3P[4] | 3 (7.0) | 4 (19.0) | 10 (13.2) | 2 (5.1) | 19 (10.6) |
G1P[4] | 4 (9.3) | 0 | 4 (5.3) | 10 (25.6) | 18 (10.1) |
G9P[4] | 2 (4.7) | 1 (4.8) | 2 (2.6) | 2 (5.1) | 7 (3.9) |
G1P[6] | 0 | 0 | 1 (1.3) | 1 (2.6) | 2 (1.1) |
G2P[8] | 0 | 0 | 1 (1.3) | 0 | 1 (0.6) |
subtotal | 9 (20.1) | 5 (23.8) | 18 (23.7) | 15 (38.4) | 47 (26.3) |
Multiple genotypes | |||||
G1P[4]P[8] | 8 (18.6) | 0 | 9 (11.8) | 7 (17.9) | 24 (13.4) |
G1G2P[4] | 2 (4.7) | 1 (4.8) | 3 (3.9) | 1 (2.6) | 7 (3.9) |
G9P[4]P[8] | 0 | 2 (9.5) | 0 | 2 (5.1) | 4 (2.2) |
G3P[4]P[8] | 0 | 0 | 3 (3.9) | 1 (2.6) | 4 (2.2) |
G1G4P[6] | 1 (2.3) | 0 | 1 (1.3) | 1 (2.6) | 3 (1.7) |
G1G3P[4]P[8] | 1 (2.3) | 0 | 1 (1.3) | 0 | 2 (1.1) |
G1G9P[8] | 0 | 0 | 2 (2.6) | 0 | 2 (1.1) |
G1G3P[8] | 0 | 0 | 1 (1.3) | 0 | 1 (0.6) |
G1G4P[8] | 1 (2.3) | 0 | 0 | 0 | 1 (0.6) |
G2G3P[4] | 1 (2.3) | 0 | 0 | 0 | 1 (0.6) |
G2P[4]P[8] | 1 (2.3) | 1 (4.8) | 0 | 0 | 2 (1.1) |
subtotal | 15 (34.9) | 4 (19.0) | 20 (26.3) | 12 (30.8) | 51 (28.5) |
nontypeable | |||||
none | 1 (2.3) | 0 | 2 (2.6) | 0 | 3 (1.7) |
P[4] | 0 | 0 | 2 (2.6) | 0 | 2 (1.1) |
G9 | 0 | 0 | 1 (1.3) | 0 | 1 (0.6) |
subtotal | 1 (2.3) | 0 | 5 (6.5) | 0 | 6 (3.4) |
Total | 43 (100) | 21 (100) | 76 (100) | 39 (100) | 179 (100) |